Regeneron leads big data sequencing effort

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced a consortium of six biotech and pharmas to speed up exome sequencing of genetic data from samples in the UK Biobank.

UK Biobank debuted in 2012 with blood,

Read the full 328 word article

User Sign In